Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

AGN 3Q17 CC slides:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 720
Posts 108,469
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
WeissLaw LLP Investigates Allergan Plc PR Newswire (US) - 6/25/2019 6:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 5:20:18 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/25/2019 5:18:31 PM
S&P Puts AbbVie on Watch Negative After Allergan Deal Dow Jones News - 6/25/2019 2:37:00 PM
AbbVie Agrees to Buy Allergan for More Than $60 Billion--6th Update Dow Jones News - 6/25/2019 11:44:00 AM
AbbVie Agrees to Buy Allergan for More Than $60 Billion--5th Update Dow Jones News - 6/25/2019 10:53:00 AM
AbbVie Agrees to Buy Allergan for More Than $60 Billion--4th Update Dow Jones News - 6/25/2019 10:06:00 AM
Stocks to Watch: AbbVie, Allergan, FedEx, Tesla, FactSet Research Systems, Kellogg, Lennar Dow Jones News - 6/25/2019 9:20:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--3rd Update Dow Jones News - 6/25/2019 8:05:00 AM
Global Stocks Waver as Gold and Bitcoin Soar Dow Jones News - 6/25/2019 7:56:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--2nd Update Dow Jones News - 6/25/2019 7:34:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion--Update Dow Jones News - 6/25/2019 7:02:00 AM
AbbVie Nears Deal to Buy Allergan for More Than $60 Billion Dow Jones News - 6/25/2019 6:56:00 AM
AbbVie to Acquire Allergan in Transformative Move for Both Companies PR Newswire (US) - 6/25/2019 6:42:00 AM
Allergan Receives FDA Clearance For CoolTone™ Device PR Newswire (US) - 6/24/2019 7:30:00 AM
FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity PR Newswire (US) - 6/21/2019 7:30:00 AM
Ironwood & Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bo... Business Wire - 6/18/2019 4:05:00 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/17/2019 5:02:19 PM
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire (US) - 6/13/2019 7:13:00 PM
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar... PR Newswire (US) - 5/28/2019 7:30:00 AM
Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/24/2019 4:05:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/23/2019 4:18:09 PM
Allergan to Present at the Jefferies 2019 Healthcare Conference PR Newswire (US) - 5/23/2019 7:30:00 AM
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire (US) - 5/17/2019 7:30:00 AM
Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/16/2019 7:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist